Recipient Organization
PRAIRIE VIEW A&M UNIVERSITY
P.O. Box 519, MS 2001
PRAIRIE VIEW,TX 77446
Performing Department
CARC
Non Technical Summary
Consumers have an increased interest in nutrition as foods have been linked to health and wellness, primarily in the control of obesity, which constitutes a substantial risk for hypertension, type-2 diabetes,cardiovascular diseases and certain cancers. One third of the adult population in US is obese and 17% of children suffer from obesity. Since obesity continues to be an important problem, developing effective preventive measures to reduce obesity and ease the medical and economic burden of these diseases, which amounts to billions of dollars annually on the population, is essential. Fucoxanthin has been reported to exhibit anti-obesity, anti-diabetic, and anti-inflammatory activities. This research proposal will assess the effect of supplementation of fucoxanthin, an anti-obesity biofunctional ingredient, on the quality and acceptability of goat dairy foods. Four goat dairy products (milk, yogurt, cheese, and ice cream) will be prepared containing fucoxanthin as a supplement at 2.4 mg per serving size, which has been shown to be the minimum concentration for anti-obesity effect in human studies. The physicochemical and sensory properties, and acceptability of goat dairy products with fucoxanthin will be studied immediately after production and during storage. Successful supplementation of fucoxanthin into stable and acceptable quality goat dairy products with health benefits will support the USDA-NIFA priority area of health and nutrition affecting the well-being of the population. Thus, this proposal may play a significant role in enhancing advanced research in healthy goat dairy products and can open up avenues of market opportunities for limited resource producers and the food industry. .
Animal Health Component
30%
Research Effort Categories
Basic
20%
Applied
30%
Developmental
50%
Goals / Objectives
Consumers have an increased interest in nutrition as foods have been linked to health and wellness, primarily in the control of obesity, which constitutes a substantial risk for hypertension, type-2 diabetes, cardiovascular diseases and certain cancers. One third of the adult population in US is obese and 17% of children suffer from obesity. Since obesity continues to be an important problem, developing effective preventive measures to reduce obesity and ease the medical and economic burden of these diseases on the population is essential. Fucoxanthin has been reported to exhibit anti-obesity, anti-diabetic, and anti-inflammatory activities. This research proposal will assess the effect of supplementation of fucoxanthin, an anti-obesity biofunctional ingredient, on the quality and acceptability of goat dairy foods. Four goat dairy products (milk, yogurt, cheese, and ice cream) will be prepared containing fucoxanthin as a supplement at 2.4 mg per serving size, which has been shown to be the minimum concentration for anti-obesity effect in human studies. The physicochemical and sensory properties, and acceptability of goat dairy products with fucoxanthin will be studied immediately after production and during storage. Successful supplementation of fucoxanthin into stable and acceptable quality goat dairy products with health benefits will support the USDA-NIFA priority area of health and nutrition affecting the well-being of the population. Thus, this proposal may play a significant role in enhancing advanced research in healthy goat dairy products and can open up avenues of market opportunities for limited resource producers and the food industry.The overall objective of this project is to develop and evaluate the sensory, physicochemical characteristics, and acceptability of goat dairy products containing fucoxanthin as an anti-obesity biofunctional ingredient. Successful implementation of this project will support the NIFA-CBG Program priority area of human health and obesity as it relates to nutrition. This will be accomplished in part by the development and evaluation of nutritious and healthy value-added goat dairy products from Alpine goats raised on the PVAMU Farm. The specific objectives of this study are to: (a) develop and evaluate sensory and physicochemical characteristics of goat milk containing fucoxanthin after production and during storage at 4°C for 3 weeks; (b) develop and evaluate sensory and physicochemical characteristics of goat milk yogurt containing fucoxanthin after production and during storage at 4°C for 3 months; (c) develop and evaluate sensory and physicochemical characteristics of goat cheese containing fucoxanthin after production and during storage at 4°C for 3 months; (d) develop and evaluate sensory and physicochemical characteristics of goat milk ice cream containing fucoxanthin after production and during storage at -26°C for 3 months.
Project Methods
We propose to develop and evaluate the sensory, physicochemical properties, and acceptability of four goat dairy products (pasteurized milk, yogurt, cheese, and ice cream). Raw whole goat milk will be obtained from the International Goat Research Center (IGRC) at PVAMU. A normal pasteurization technique that is used in the industry will be applied to raw goat milk (65°C x 30 min). Prior to the pasteurization and homogenization steps, fucoxanthin will be added to milk such that the final concentration in the product is equivalent to 2.4 mg in 250 ml of milk, which is one serving size (Mok et al., 2016). This concentration is also the minimum level of fucoxanthin demonstrated to have an anti-obesity effect in humans (Abidov et al., 2010) and will be added to all of goat dairy products. After successful completion of fucoxanthin supplementation in goat milk, the team will devote efforts to determine the stability and degradation rate of fucoxanthin-casein complex during the storage of milk. Goat milk without fucoxanthin (control) and goat milk supplemented with fucoxanthin (treatment) will be evaluated for sensory attributes, acceptability, and storage stability according to the outlined protocol (Figure 1, Appendix) of the proposal.Goat milk yogurt will be manufactured from whole milk with the addition of powdered goat milk to constitute 14.4% total solids (TS) to simulate commercial regular yogurt. Freeze-dried lactic acid culture containing Lactobacillus bulgaricus, Lactobacillus thermophilus, and Lactobacillus acidophilus will be added to the final mix according to the method of Attaie et al. (1987). The mix will be fermented in a culture tank at 40oC and interrupted by cooling when the pH value of yogurt reaches 4.2 to 4.3. The fucoxanthin content will be added such that the final concentration in the product is equivalent to 2.4 mg fucoxanthin/170 g of yogurt (1 serving size = 1 container, 170 g). Yogurt without fucoxanthin (control) and with added fucoxanthin (treatment) will be evaluated for sensory attributes, acceptability, and storage stability.Soft goat cheese (Chevre) will be manufactured according to the method described in the book "Fabrication of Farmstead Goat Cheese" (Le Jaouen, 1990). Likewise, goat milk cheese will be supplemented with fucoxanthin to form fucoxanthin-casein complex in the cheese matrix. The adjunct Lactobacillus casei variant A (Figure 2, Appendix) will be used to favor not only the development of the organoleptic characteristics of soft goat milk cheese, but also the formation of the amino acids tryptophan (Trp) and tyrosine (Tyr), which are involved in the binding of fucoxanthin to casein. The quantity of fucoxanthin will be added such that the final concentration in the product is equivalent to 2.4 mg of fucoxanthin/28 g of cheese (1 serving size = 1 slice, 28g). Soft goat cheese without fucoxanthin (control) and with added fucoxanthin (treatment) will be evaluated for sensory attributes, acceptability, and storage stability.Goat milk ice cream will be made according to the method that was developed at the PVAMU creamery (Attaie; unpublished data). Goat milk ice cream made at the PVAMU creamery was popular on campus and had the following composition: 12% fat, 11% milk solids not fat (MSNF), 15% sugar, 0.3% stabilizer, and 38.3% total solids. According to the marketability survey conducted at the University campus, the goat milk chocolate and vanilla ice creams were scored high and liked very much. Fucoxanthin will be added to ice cream mix such that the final concentration in the product is equivalent to 2.4 mg fucoxanthin per 4 fl. oz of ice cream (1 serving size = ½ cup, 4 fl. oz). Vanilla ice cream made from goat milk without fucoxanthin (control) and with added fucoxanthin (treatment) will be evaluated for sensory attributes, acceptability, and storage stability. After standardizing the techniques for achieving the required fucoxanthin concentrations in the dairy products, at least three replicates of each experiment will be conducted and data collected for statistical analysis.